Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd (600671.SS) SHH

Currency In CNY

AD

Valuation

Market Cap2.11B
Enterprise Value2.25B
P/E Ratio200.53
PEG Ratio-2.89
Price/Sales Ratio13.22
Price/Book Ratio35.83
Enterprise/Revenue13.79
Enterprise/EBITDA80.93

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.07
Operating Margin0.05
AD

Management Effectiveness

Return On Assets0.03
Return On Equity0.19

Income Statement

Revenue210.66M
Revenue/Share1.71
Gross Profit82.33M
EBITDA51.08M
Net Income17.62M
Diluted EPS0.14

Balance Sheet

Total Cash70.11M
Total Cash/Share0.58
Total Debt189.76M
Total Debt/Equity2.49
Current Ratio0.84
Book Value Per Share0.81

Price History

52-Week Change22.32
52-Week High24.25
52-Week Low15.7
Moving Average 50 Days20.83
Moving Average 200 Days19.47

Statistics

Average Volume4.56M
Shares Outstanding121.78M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0.36
Last Split Factor10177:10000
Last Split DateMay 04, 2009
AD